Navigation Links
Sanofi-aventis Delivers 2008 Results Above Guidance
Date:2/11/2009

irbesartan is protected by a patent in the principal European countries until August 2012. In some countries (Spain, Portugal, Finland, Norway, and some Eastern European countries), irbesartan is not protected by this active ingredient patent, though other patents may be in force locally. Net sales of Aprovel(R) as a monotherapy in European countries not covered by the active ingredient patent were approximately EUR 50 million in 2008.

Human Vaccines

Fourth-quarter consolidated net sales for the Human Vaccines business were up 8.9% at EUR 709 million, with full-year growth reaching 9.6% at EUR 2,861 million. In the United States, 2008 full-year net sales were up 9.7% at EUR 1,683 million.

Net sales of influenza vaccines in 2008 rose 1.5% to EUR 736 million. This increase includes the shipment during the second quarter of a batch of H5N1 vaccine to the U.S. Department of Health and Human Services worth $192.5 million (vs. $113 million in 2007). Fourth-quarter sales of influenza vaccines in the United States were down compared to previous year, as three-quarters of 2008 shipments were completed during the third quarter of the year.

Net sales of Menactra(R) (quadrivalent meningococcal meningitis vaccine) rose 7.9% in 2008 at EUR 404 million.

Pentacel(R) -- the first 5-in-1 pediatric combination vaccine to protect against diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b licensed in the United States-- confirmed its success with strong sales uptake promptly after its launch in July 2008, reaching net sales of EUR 56 million in the fourth quarter and EUR 82 million in 2008.

Adacel(R) (adult and adolescent tetanus-diphtheria-pertussis booster) continued to perform very well in the United States, up 35.6% in the fourth quarter to EUR 54 million and by 20.0% for the year, reaching EUR 255
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care
2. Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care
3. Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
4. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
5. Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured
6. Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):
7. Sanofi-aventis Teams With HHS Quality Agency to Distribute Consumer Health Materials
8. Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health
9. Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
10. TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement
11. Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Dr. Shervin Naderi, MD, FACS, one of the ... recipient of the 2014 Vitals Top 10 Doctor Award. This ... as it honors physicians that have earned the highest patient ... by his plastic surgeon colleagues as “The Nose Man,” is ... surgeons in the world. He is the founder of ...
(Date:9/17/2014)... September 17, 2014 Promising new research ... sheds more light on the potential ability of ketones ... disease dementia. The study shows that ... be caused by impaired glucose uptake and/or utilization, and ... brain function. , The study, by the Research Center ...
(Date:9/17/2014)... 2014) A study led by St. Jude Children,s ... threshold below which male childhood cancer survivors are ... appears in September 17 edition of the journal ... patients are at highest risk for reduced sperm ... eventually increase use of pre-treatment fertility preservation methods ...
(Date:9/17/2014)... leads to an explosion of flavours in your mouth. Researchers ... can mimic what happens in your mouth when you drink ... dryness in the wine. , When wine growers turn their ... processes to bring out the desired flavour in the product ... of the taste is known in wine terminology as astringency, ...
(Date:9/17/2014)... Los Angeles, CA (PRWEB) September 17, 2014 ... Indian news outlet, tells of a 24-year-old man named Advait ... severe back pain caused by degenerative disc disease. This ... putting pressure on his nerve roots and causing severe ... degenerative disc disease and how it can lead to ...
Breaking Medicine News(10 mins):Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 2Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 3Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 3Health News:Improved risk identification will aid fertility preservation in young male cancer patients 2Health News:Improved risk identification will aid fertility preservation in young male cancer patients 3Health News:Nanoscience makes your wine better 2Health News:Nanoscience makes your wine better 3Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 2Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 3
... reactions to a,prescribed medication send more than 175,000 older ... used medications -- almost all,of them for heart disease ... March 2008 issue of the Harvard Heart Letter offers ... Warfarin: Check your bleeding time (INR) regularly. Take ...
... and Amortization Increased ... 3.85% and 2.96%, Respectively, MEXICO CITY, ... "the Group"), one of the leading Mexican,distributors of pharmaceutical products, ... other products,announces its consolidated financial and operating results for the ...
... is a,statement by William V. Corr, Executive Director, ... restaurants, bars and gaming,facilities, will be smoke-free beginning ... the Legislature last week and signed,into law today ... have delivered a historic victory for public health ...
... West announced today,that one of the country,s most iconic ... The Shops at The Bravern in downtown Bellevue as ... the needs of approximately 2,300,Microsoft employees who will be ... this fall., DavidBartonGym will offer Barton,s world renowned ...
... Over 200,of MemorialCare,s top leaders will participate in ... Habitat for Humanity of Orange County. The,home will be ... cerebral palsy and is confined to a wheelchair. Halls ... will be given a "makeover" with,upgrades throughout., (Photo: ...
... patient acceptance and ... ... that treats acute and chronic constipation, may be an,effective option for ... PEG 3350 products. Marketed in the,U.S. by Cumberland Pharmaceuticals, Kristalose(R) is ...
Cached Medicine News:Health News:Tips for Troublesome Medications, From the Harvard Heart Letter 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 3Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 4Health News:Nebraska's New Smoke-Free Law is Historic Win for Health 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 3Health News:MemorialCare Sponsors Habitat for Humanity Santa Ana Home 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 3
(Date:9/17/2014)... 17, 2014  NuView Life Sciences, Inc. (NuView) ... collaboration agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) ... diagnostic biomarker to detect cancers of the breast ... future diagnostic-imaging applications. NuView retains all rights for ... in-vitro urine screen applications. Under the ...
(Date:9/17/2014)... Calif. , Sept. 17, 2014 ... announced that it has earned a $4 million ... AKAO ) associated with the initiation of a ... serious multi-drug resistant (MDR), gram-negative bacterial infections.  The ... study to evaluate the efficacy and safety of ...
(Date:9/17/2014)...  Trovagene, Inc., (NASDAQ:   TROV) a developer of ... , Ph.D., has joined the Company,s Scientific Advisory Board. ... in the kinase genes that are associated with colorectal ... Department of Oncology, Torino Medical School, Institute for Cancer ... "Alberto,s work in cancer genomics has had ...
Breaking Medicine Technology:NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 2Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 3Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 2Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 3
... global provider of advanced analytical instruments for laboratories and ... MultiTek(TM) testing system for the fast, accurate detection of ... include BioFuels, Chemicals, Food & Beverage, Manufacturing and Assembly, ... is the only instrument on the market that combines ...
... personalized medicine advances will create therapies that are so effective, ... to gain access, the inventor of the DNA gene sequencer ... Personalized Health Care National Conference . , ... said personalized medicine,s first "killer apps" - therapies that will ...
Cached Medicine Technology:New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides 2Personalized Medicine 'Killer Apps' Will Transform Care Model 2
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: